T1	Age 2 13	31-year-old
T2	Sex 14 17	man
T3	Disease_disorder 28 46	diabetes insipidus
E1	Disease_disorder:T3 
T4	Diagnostic_procedure 52 64	urine volume
E2	Diagnostic_procedure:T4 
T5	Volume 71 81	10 to 20 L
T6	Frequency 82 96	every 24 hours
R1	MODIFY Arg1:T6 Arg2:T5	
R2	MODIFY Arg1:T5 Arg2:E2	
T7	Date 100 104	2003
E3	Date:T7 
T8	Date 106 122	Four years later
E4	Date:T8 
T9	Sign_symptom 141 148	fatigue
E5	Sign_symptom:T9 
T10	Sign_symptom 150 158	anorexia
E6	Sign_symptom:T10 
T11	Sign_symptom 160 168	jaundice
E7	Sign_symptom:T11 
T12	Sign_symptom 173 181	pruritus
E8	Sign_symptom:T12 
T13	Sign_symptom 211 215	mass
E9	Sign_symptom:T13 
T14	Detailed_description 189 200	symptomatic
T15	Biological_structure 201 210	occipital
R3	MODIFY Arg1:T15 Arg2:E9	
R4	MODIFY Arg1:T14 Arg2:E9	
T16	Diagnostic_procedure 217 233	Laboratory tests
E10	Diagnostic_procedure:T16 
T17	Diagnostic_procedure 253 265	liver enzyme
E11	Diagnostic_procedure:T17 
T18	Lab_value 244 252	abnormal
R5	MODIFY Arg1:T18 Arg2:E11	
R6	SUB_PROCEDURE Arg1:E11 Arg2:E10	
T19	Diagnostic_procedure 307 324	hepatitis viruses
E12	Diagnostic_procedure:T19 
T20	Lab_value 294 302	negative
R7	MODIFY Arg1:T20 Arg2:E12	
R8	SUB_PROCEDURE Arg1:E12 Arg2:E10	
T21	Diagnostic_procedure 355 358	MRI
E13	Diagnostic_procedure:T21 
T22	Biological_structure 345 354	abdominal
R9	MODIFY Arg1:T22 Arg2:E13	
T23	Sign_symptom 387 394	lesions
E14	Sign_symptom:T23 
T24	Detailed_description 375 386	low-density
T25	Detailed_description 366 374	multiple
R10	MODIFY Arg1:T24 Arg2:E14	
R11	MODIFY Arg1:T25 Arg2:E14	
T26	Biological_structure 402 407	liver
R12	MODIFY Arg1:T26 Arg2:E14	
T27	Diagnostic_procedure 415 432	T1-weighted image
E15	Diagnostic_procedure:T27 
R13	SUB_PROCEDURE Arg1:E15 Arg2:E13	
T28	Diagnostic_procedure 492 509	T2-weighted image
E16	Diagnostic_procedure:T28 
R14	SUB_PROCEDURE Arg1:E16 Arg2:E13	
T29	Sign_symptom 445 454	expansion
E17	Sign_symptom:T29 
T30	Severity 437 444	obvious
R15	MODIFY Arg1:T30 Arg2:E17	
T31	Biological_structure 462 484	intrahepatic bile duct
R16	MODIFY Arg1:T31 Arg2:E17	
R17	MODIFY Arg1:E17 Arg2:E16	
R18	MODIFY Arg1:E14 Arg2:E15	
T32	Diagnostic_procedure 511 554	Magnetic resonance cholangiopancreatography
E18	Diagnostic_procedure:T32 
T33	Sign_symptom 598 608	strictures
E19	Sign_symptom:T33 
T34	Sign_symptom 613 623	dilatation
E20	Sign_symptom:T34 
T35	Disease_disorder 693 695	SC
E21	Disease_disorder:T35 
#1	AnnotatorNotes E21	sclerosing cholangitis
T36	Biological_structure 575 597	intrahepatic bile duct
T37	Detailed_description 564 574	multifocal
R19	MODIFY Arg1:T36 Arg2:E19	
R20	MODIFY Arg1:T36 Arg2:E20	
R21	MODIFY Arg1:T37 Arg2:E19	
T38	Diagnostic_procedure 633 652	common hepatic duct
E22	Diagnostic_procedure:T38 
T39	Lab_value 657 663	normal
R22	MODIFY Arg1:T39 Arg2:E22	
T40	Diagnostic_procedure 723 726	MRI
E23	Diagnostic_procedure:T40 
T41	Biological_structure 701 722	neurohypophyseal area
R23	MODIFY Arg1:T41 Arg2:E23	
T42	Sign_symptom 738 747	thickened
E24	Sign_symptom:T42 
T43	Biological_structure 748 767	hypothalamic nuclei
R24	MODIFY Arg1:T43 Arg2:E24	
T44	Sign_symptom 786 792	signal
E25	Sign_symptom:T44 
T45	Detailed_description 774 785	low-density
R25	MODIFY Arg1:T45 Arg2:E25	
T46	Area 796 808	4.9 × 5.6 mm
R26	MODIFY Arg1:T46 Arg2:E25	
T47	Biological_structure 824 851	hypothalamic-pituitary area
R27	MODIFY Arg1:T47 Arg2:E25	
T48	Disease_disorder 884 887	LCH
E26	Disease_disorder:T48 
#2	AnnotatorNotes E26	Langerhans cell histiocytosis
T49	Detailed_description 878 883	organ
T50	Severity 868 877	high-risk
T51	Detailed_description 855 866	multisystem
R28	MODIFY Arg1:T49 Arg2:E26	
R29	MODIFY Arg1:T50 Arg2:E26	
R30	MODIFY Arg1:T51 Arg2:E26	
T52	Diagnostic_procedure 927 935	biopsied
E27	Diagnostic_procedure:T52 
T53	Nonbiological_location 943 957	local hospital
R31	MODIFY Arg1:T53 Arg2:E27	
T54	Sign_symptom 918 922	mass
E28	Sign_symptom:T54 
R32	MODIFY Arg1:E28 Arg2:E27	
T55	Biological_structure 908 917	occipital
R33	MODIFY Arg1:T55 Arg2:E28	
T56	Medication 981 1001	ursodeoxycholic acid
E29	Medication:T56 
T57	Dosage 1002 1022	150 mg 3 times a day
R34	MODIFY Arg1:T57 Arg2:E29	
T58	Medication 1062 1079	COEP chemotherapy
E30	Medication:T58 
T59	Medication 1081 1097	cyclophosphamide
E31	Medication:T59 
T60	Medication 1108 1119	vincristine
E32	Medication:T60 
T61	Medication 1127 1137	epirubicin
E33	Medication:T61 
T62	Medication 1150 1160	prednisone
E34	Medication:T62 
T63	Dosage 1099 1106	1000 mg
T64	Dosage 1121 1125	2 mg
T65	Dosage 1139 1144	90 mg
T66	Dosage 1162 1167	90 mg
R35	MODIFY Arg1:T63 Arg2:E31	
R36	MODIFY Arg1:T64 Arg2:E32	
R37	MODIFY Arg1:T65 Arg2:E33	
R38	MODIFY Arg1:T66 Arg2:E34	
T67	Date 1172 1176	2009
E35	Date:T67 
R39	SUB_PROCEDURE Arg1:E31 Arg2:E30	
R40	SUB_PROCEDURE Arg1:E32 Arg2:E30	
R41	SUB_PROCEDURE Arg1:E33 Arg2:E30	
R42	SUB_PROCEDURE Arg1:E34 Arg2:E30	
T68	Medication 1359 1371	chemotherapy
E36	Medication:T68 
A1	POLARITY E36 NEG
T69	Date 1194 1201	5th day
E37	Date:T69 
T70	Medication 1213 1230	COEP chemotherapy
E38	Medication:T70 
T71	Diagnostic_procedure 1313 1328	serum bilirubin
E39	Diagnostic_procedure:T71 
T72	Lab_value 1301 1309	increase
T73	Severity 1293 1300	obvious
R43	MODIFY Arg1:T73 Arg2:T72	
R44	MODIFY Arg1:T72 Arg2:E39	
T74	Disease_disorder 1269 1284	function injury
E40	Disease_disorder:T74 
T75	Biological_structure 1263 1268	liver
T76	Severity 1256 1262	severe
R45	MODIFY Arg1:T75 Arg2:E40	
R46	MODIFY Arg1:T76 Arg2:E40	
T77	Date 1373 1387	One year later
E41	Date:T77 
T78	Disease_disorder 1417 1431	decompensation
E42	Disease_disorder:T78 
T79	Biological_structure 1411 1416	liver
R47	MODIFY Arg1:T79 Arg2:E42	
T80	Sign_symptom 1457 1464	varices
E43	Sign_symptom:T80 
T81	Sign_symptom 1466 1473	ascites
E44	Sign_symptom:T81 
T82	Sign_symptom 1479 1491	splenomegaly
E45	Sign_symptom:T82 
T83	Biological_structure 1446 1456	esophageal
T84	Detailed_description 1437 1445	bleeding
R48	MODIFY Arg1:T83 Arg2:E43	
R49	MODIFY Arg1:T84 Arg2:E43	
T85	Therapeutic_procedure 1516 1518	LT
E46	Therapeutic_procedure:T85 
#3	AnnotatorNotes E46	 liver transplantation
T86	Therapeutic_procedure 1600 1602	LT
E47	Therapeutic_procedure:T86 
T87	Diagnostic_procedure 1520 1553	Model for End Stage Liver Disease
E48	Diagnostic_procedure:T87 
T88	Lab_value 1560 1562	17
R50	MODIFY Arg1:T88 Arg2:E48	
T89	Detailed_description 1589 1599	orthotopic
R51	MODIFY Arg1:T89 Arg2:E47	
T90	Date 1606 1619	November 2011
E49	Date:T90 
T91	Nonbiological_location 1627 1633	center
R52	MODIFY Arg1:T91 Arg2:E47	
T92	Subject 1643 1648	donor
T93	Nonbiological_location 1704 1709	China
T94	Detailed_description 1659 1685	voluntary deceased citizen
R53	MODIFY Arg1:T94 Arg2:T92	
R54	MODIFY Arg1:T93 Arg2:T92	
T95	Diagnostic_procedure 1711 1731	Liver histopathology
E50	Diagnostic_procedure:T95 
T96	Therapeutic_procedure 1738 1740	LT
E51	Therapeutic_procedure:T96 
T97	Disease_disorder 1778 1780	SC
E52	Disease_disorder:T97 
#4	AnnotatorNotes E52	sclerosing cholangitis
T98	Diagnostic_procedure 1794 1808	immunostaining
E53	Diagnostic_procedure:T98 
T99	Diagnostic_procedure 1810 1814	CD1a
E54	Diagnostic_procedure:T99 
T100	Diagnostic_procedure 1819 1823	S100
E55	Diagnostic_procedure:T100 
T101	Lab_value 1785 1793	positive
R55	MODIFY Arg1:T101 Arg2:E53	
R56	SUB_PROCEDURE Arg1:E54 Arg2:E53	
R57	SUB_PROCEDURE Arg1:E55 Arg2:E53	
T102	Disease_disorder 1840 1843	LCH
E56	Disease_disorder:T102 
T103	Biological_structure 1861 1866	liver
R58	MODIFY Arg1:T103 Arg2:E56	
T104	Disease_disorder 1763 1772	cirrhosis
E57	Disease_disorder:T104 
T105	Detailed_description 1750 1762	micronodular
R59	MODIFY Arg1:T105 Arg2:E57	
T106	Disease_disorder 1917 1933	immunosuppressed
E58	Disease_disorder:T106 
T107	Medication 1939 1949	tacrolimus
E59	Medication:T107 
#5	AnnotatorNotes E58	Intentional (after organ transplant)
T108	Medication 1954 1974	mycofenolate mofetil
E60	Medication:T108 
T109	Sign_symptom 2001 2005	well
E61	Sign_symptom:T109 
T110	Diagnostic_procedure 2018 2032	liver function
E62	Diagnostic_procedure:T110 
T111	Lab_value 2011 2017	normal
R60	MODIFY Arg1:T111 Arg2:E62	
T112	Sign_symptom 2052 2062	recurrence
E63	Sign_symptom:T112 
A2	POLARITY E63 NEG
T113	Disease_disorder 2066 2069	LCH
E64	Disease_disorder:T113 
R61	MODIFY Arg1:E64 Arg2:E63	
T114	Date 2074 2092	4 and a half years
E65	Date:T114 
T115	Clinical_event 2093 2102	follow-up
E66	Clinical_event:T115 
*	OVERLAP E1 E2 E3
R62	BEFORE Arg1:E3 Arg2:E4	
*	OVERLAP E4 E5 E6 E7 E8 E9 E10 E13 E14 E17 E18 E19 E20 E22 E21 E23 E24 E25
R63	BEFORE Arg1:E25 Arg2:E26	
R64	AFTER Arg1:E26 Arg2:E28	
*	OVERLAP E28 E27
R65	BEFORE Arg1:E27 Arg2:E29	
R66	BEFORE Arg1:E29 Arg2:E30	
*	OVERLAP E30 E35
R67	BEFORE Arg1:E35 Arg2:E37	
*	OVERLAP E37 E38 E40 E39
R68	BEFORE Arg1:E39 Arg2:E36	
R69	BEFORE Arg1:E36 Arg2:E41	
*	OVERLAP E41 E42 E43 E44 E45 E67
T116	Clinical_event 1504 1512	referred
E67	Clinical_event:T116 
R70	BEFORE Arg1:E67 Arg2:E46	
R71	AFTER Arg1:E46 Arg2:E48	
R72	BEFORE Arg1:E48 Arg2:E47	
*	OVERLAP E47 E49
R73	MODIFY Arg1:T92 Arg2:E47	
R74	BEFORE Arg1:E49 Arg2:E50	
R75	AFTER Arg1:E50 Arg2:E51	
R76	BEFORE Arg1:E51 Arg2:E57	
*	OVERLAP E57 E52 E53 E56
R77	BEFORE Arg1:E56 Arg2:E58	
*	OVERLAP E58 E59 E60
R78	BEFORE Arg1:E60 Arg2:E61	
*	OVERLAP E61 E62 E63 E65 E66
